Market Place
Sourcing Support
GSK Resubmits Tebipenem Hbr NDA To FDA For Complicated Utis
19 Dec 2025 //
GLOBENEWSWIRE
GSK`s Long-Acting Asthma Med Wins CHMP Backing
12 Dec 2025 //
FIERCE PHARMA
FDA Signs Off On Expansion For Gsk`s Blujepa To Treat Gonorrhea
12 Dec 2025 //
FIERCE PHARMA
Sanofi, GSK Ink Preclinical Pacts In Hunt For New Antibodies
10 Dec 2025 //
FIERCE BIOTECH
Oxford Biotherapeutics Collaborates With GSK On Cancer Antibody
10 Dec 2025 //
PHARMIWEB
GSK Cuts Five-Year-Old Cancer Collaboration With Ideaya
09 Dec 2025 //
BIOSPACE
GSK India Plans Big `Reinvention`, MD Bhushan Akshikar Reveals
05 Dec 2025 //
ECONOMICTIMES
Pfizer, GSK, Shionogi Sponsor London Run Of AMR Musical
04 Dec 2025 //
FIERCE PHARMA
Haleon May Rope In Ex-Md Of Castrol India To Head Local Biz
29 Nov 2025 //
ECONOMICTIMES
GSK, Anaptysbio sue each other over Jemperli revenue
22 Nov 2025 //
BIOPHARMADIVE
GSK Fleming Initiative Launch New Fight Against Antimicrobial
21 Nov 2025 //
INDPHARMAPOST
GSK Partners LTZ Therapeutics For Advanced Cancer Treatments
21 Nov 2025 //
INDPHARMAPOST
GSK Picks 1st Biotech Partners Under $7 B Flagship Pact
20 Nov 2025 //
FIERCE BIOTECH
Flagship Signs ProFound, Quotient Deals in GSK Pact
20 Nov 2025 //
PR NEWSWIRE
Scynexis Transfers Brexafemme NDA to Gsk
19 Nov 2025 //
GLOBENEWSWIRE
GSK Pens $50M Pact To Join Big Pharma Peers In Emerging Modality
19 Nov 2025 //
FIERCE BIOTECH
Life Sciences` Top Women of 2025
17 Nov 2025 //
FIERCE PHARMA
BDCDA Protests GSK`s Circular On Expired Drug Return Policy
12 Nov 2025 //
PHARMABIZ
GSK & AN2 Partner on Boron-Based LeuRS Inhibitors for TB
10 Nov 2025 //
BUSINESS WIRE
NPPA Revokes Decision Denying GSK`s Antifungal Formulation
08 Nov 2025 //
PHARMABIZ
Pediatrician Group Declines to Back Leucovorin for Autism
31 Oct 2025 //
FIERCE PHARMA
GSK Points To `Macro Factors` To Explain US Shingrix Demand Crash
29 Oct 2025 //
BIOSPACE
Emma Walmsley Upholds £40B Sales Target In Final GSK CEO Report
29 Oct 2025 //
FIERCE PHARMA
GSK Loses Hope For CD226 Cancer Therapies, Dropping Ph. 2 Assets
29 Oct 2025 //
FIERCE BIOTECH
Viiv Healthcare Initiates `Risk To Reasons` Program for Women
28 Oct 2025 //
PHARMIWEB
GSK Pens $750M Deal For COPD-Focused Oligonucleotide In Phase 1
28 Oct 2025 //
FIERCE BIOTECH
Biogen Seeks To Stand Out In Lupus With New Anti-CD40L Data
28 Oct 2025 //
BIOSPACE
GSK Acquires Prostate-Cancer Candidate From Syndivia For £268M
27 Oct 2025 //
FIERCE BIOTECH
New Global Coalition Launches to Hidden Threat of RSV in Adults
26 Oct 2025 //
GLOBENEWSWIRE
US FDA Approves Gsk`s Blood Cancer Treatment
25 Oct 2025 //
REUTERS
Glaxosmithkline’s Biologics Blenrep Receives Approval in US
23 Oct 2025 //
FDA
GSK Unveils Pivotal Data on Oral Antibiotic Ahead of FDA Filing
22 Oct 2025 //
PRESS RELEASE
GSK And Viiv Healthcare Pledge £6M To Boost Community Health
21 Oct 2025 //
PHARMIWEB
Ph3 PIVOT-PO Data Show Tebipenem HBr as First Oral Carbapenem
21 Oct 2025 //
GLOBENEWSWIRE
GSK`s Shingrix Prefilled Syringe Gets Positive CHMP Opinion
21 Oct 2025 //
PHARMIWEB
GSK Says `s Tuned` For More ADC Data As Hansoh Posts 49% ORR
19 Oct 2025 //
FIERCE BIOTECH
ViiV’s Dovato Matches Biktarvy Efficacy With Less Weight Gain
17 Oct 2025 //
BUSINESSWIRE
UK`s Recommends Use of GSK Unit`s HIV Prevention Drug
16 Oct 2025 //
REUTERS
Scynexis Secures $22M Payout From GSK After Trial Dispute
15 Oct 2025 //
FIERCE PHARMA
GSK Tout Study Showing Tolerability Edge for Its Long-Acting PrEP
15 Oct 2025 //
FIERCE PHARMA
GSK`s Shingrix Approved In China For Shingles Prevention
14 Oct 2025 //
PHARMIWEB
Clover Reveals Encouraging Phase I Results For RSV Vaccines
14 Oct 2025 //
PR NEWSWIRE
Spero Pharma Presents Tebipenem Hbr Data At IDweek
14 Oct 2025 //
GLOBENEWSWIRE
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo
13 Oct 2025 //
PR NEWSWIRE
GSK`s Nashik Plant Receives Global BSI AMR Kitemark Certification
13 Oct 2025 //
EXPRESSPHARMA
Kennedy Push For Autism Drug Gets A Boost From Pharma
06 Oct 2025 //
REUTERS
As 2 Ceos Depart, Life Sciences Face Leadership Void For Women
03 Oct 2025 //
FIERCE BIOTECH
GSK Overturns Pmcpa`s Most Serious Sanction In COVID Release Row
03 Oct 2025 //
FIERCE PHARMA
GSK Pharma Boosted By New Launches And Base Business Traction
02 Oct 2025 //
BUSINESS STD
GSK And Iqvia`s Vaccine Data Enhances Community Health Strategies
01 Oct 2025 //
BUSINESSWIRE
Who is GSK`s next CEO Luke Miels
30 Sep 2025 //
REUTERS
Pi Health Partners GSK To Boost Clinical Research Services
24 Sep 2025 //
BUSINESSWIRE
FDA Approves Drug that Trump Due to Suggest as Autism Treatment
24 Sep 2025 //
REUTERS
GSK Plots $30 B Investment in US Manufacturing, R&D
17 Sep 2025 //
PRESS RELEASE
GSK Adds Moderna`s Next-Gen Covid Shot to MRNA Patent Lawsuit
05 Sep 2025 //
FIERCE PHARMA
GSK forays into oncology in India with Jemperli and Zejula
25 Aug 2025 //
INDPHARMAPOST
Iterum Pursues Dual-Track Strategy for First UTI Drug in 25 Years
20 Aug 2025 //
FIERCE PHARMA
GSK`s Gepotidacin Gets Priority Review from U.S. FDA
11 Aug 2025 //
CONTRACTPHARMA
GSK Pharma Q1 PAT rises 12% to 279 cr, income marginally down
01 Aug 2025 //
BUSINESS STD
GSK anti-TIM-3 antibody flunks ph. 3, as TIGIT fail costs $629M
31 Jul 2025 //
FIERCE BIOTECH
